Pancreatic cancer rarely occurs. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Pancreas Tumor Cells, Cultured Pancreatic Ducts Pancreatic Stellate Cells Neoplastic Stem Cells Pancreatic Juice Breast Celiac Plexus Prostate

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases49

Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Adenocarcinoma Neoplasm Invasiveness Neoplasm Metastasis Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Breast Neoplasms Disease Progression Pancreatitis Colonic Neoplasms Stomach Neoplasms Neoplasms Genetic Predisposition to Disease Pancreatitis, Chronic Carcinoma Cell Transformation, Neoplastic Neovascularization, Pathologic Uterine Cervical Neoplasms Colorectal Neoplasms Liver Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Neoplasm Recurrence, Local Precancerous Conditions Urinary Bladder Neoplasms Disease Models, Animal Gastrointestinal Neoplasms Rectal Neoplasms Carcinoma in Situ Endometrial Neoplasms Esophageal Neoplasms Peritoneal Neoplasms Neoplastic Syndromes, Hereditary Adenocarcinoma, Mucinous Pancreatic Diseases Neoplasms, Experimental Head and Neck Neoplasms Cachexia Skin Neoplasms Mouth Neoplasms Neoplasms, Hormone-Dependent Carcinogenesis Carcinoma, Small Cell Neoplasms, Radiation-Induced Bone Neoplasms Neoplasms, Second Primary Neoplasms, Glandular and Epithelial

Chemicals and Drugs66

Deoxycytidine Antimetabolites, Antineoplastic CA-19-9 Antigen Antineoplastic Agents Tumor Markers, Biological Neoplasm Proteins RNA, Messenger RNA, Small Interfering Fluorouracil Cancer Vaccines DNA, Neoplasm Antigens, Neoplasm Smad4 Protein Tumor Suppressor Protein p53 MicroRNAs Antigens, Tumor-Associated, Carbohydrate Receptor, Epidermal Growth Factor Cisplatin Receptor, erbB-2 Mucin-4 Antibodies, Monoclonal Proto-Oncogene Proteins Antineoplastic Agents, Phytogenic Receptors, Estrogen RNA, Neoplasm Quinazolines ras Proteins Anticarcinogenic Agents Carcinoembryonic Antigen Protein Kinase Inhibitors Mucin-1 Tumor Suppressor Proteins Proto-Oncogene Proteins c-akt Prostate-Specific Antigen Organoplatinum Compounds DNA-Binding Proteins Paclitaxel BRCA2 Protein Vascular Endothelial Growth Factor A Transcription Factors Tamoxifen Cadherins Nuclear Proteins GPI-Linked Proteins Radiation-Sensitizing Agents Camptothecin Receptors, Progesterone NF-kappa B Antibodies, Monoclonal, Humanized Protein-Serine-Threonine Kinases Carcinogens Curcumin Antineoplastic Agents, Hormonal Enzyme Inhibitors Proto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins c-bcl-2 Cyclooxygenase 2 Cell Cycle Proteins Oxonic Acid Taxoids DNA Primers Membrane Proteins Inhibitor of Apoptosis Proteins beta Catenin STAT3 Transcription Factor Tegafur

Analytical, Diagnostic and Therapeutic Techniques and Equipment70

Early Detection of Cancer Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Prognosis Survival Analysis Survival Rate Blotting, Western Transplantation, Heterologous Pancreatectomy Combined Modality Therapy Risk Factors Neoplasm Staging Tumor Burden Immunohistochemistry Gene Expression Profiling Prospective Studies Retrospective Studies Risk Follow-Up Studies Odds Ratio Risk Assessment Registries Chemotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Disease-Free Survival Palliative Care Treatment Outcome Drug Screening Assays, Antitumor Sensitivity and Specificity Pancreaticoduodenectomy Transfection Gene Knockdown Techniques Molecular Targeted Therapy Multivariate Analysis Tissue Array Analysis Polymerase Chain Reaction Endosonography Clinical Trials as Topic SEER Program Incidence Immunoenzyme Techniques Disease Models, Animal Questionnaires Flow Cytometry Genetic Therapy Predictive Value of Tests Reproducibility of Results Case-Control Studies Cohort Studies Confidence Intervals Logistic Models Models, Biological Radiotherapy, Adjuvant Drug Delivery Systems Drug Administration Schedule DNA Mutational Analysis Radiotherapy Real-Time Polymerase Chain Reaction Neoplasm Grading Tomography, X-Ray Computed Heavy Ion Radiotherapy Mammography Tumor Stem Cell Assay Inhibitory Concentration 50 Neoplasms, Experimental Immunotherapy Enzyme-Linked Immunosorbent Assay

Psychiatry and Psychology1

Phenomena and Processes47

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Drug Resistance, Neoplasm Genetic Predisposition to Disease Cell Growth Processes Cell Survival Cell Movement Signal Transduction Mutation Risk RNA Interference Down-Regulation Genes, ras Odds Ratio Cell Division Up-Regulation Dose-Response Relationship, Drug Cell Cycle Sensitivity and Specificity Drug Synergism Gene Silencing Epithelial-Mesenchymal Transition DNA Methylation Transfection Genotype Genes, Neoplasm Germ-Line Mutation Phosphorylation Promoter Regions, Genetic Genes, Tumor Suppressor Genes, BRCA1 Gene Expression Diet Time Factors Genes, BRCA2 Polymorphism, Genetic Genes, p53 Base Sequence Tumor Microenvironment Phenotype Inhibitory Concentration 50 Radiation Tolerance Cell Adhesion Epigenesis, Genetic Alleles Loss of Heterozygosity

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries SEER Program Incidence Questionnaires Base Sequence Molecular Sequence Data

Named Groups1

Health Care30

Survival Analysis Survival Rate Risk Factors Prospective Studies Retrospective Studies Risk Follow-Up Studies Odds Ratio Risk Assessment Registries Kaplan-Meier Estimate Disease-Free Survival Palliative Care Treatment Outcome Sensitivity and Specificity Multivariate Analysis National Cancer Institute (U.S.)Age Factors Clinical Trials as Topic SEER Program Incidence Questionnaires Predictive Value of Tests Reproducibility of Results Case-Control Studies Cohort Studies Confidence Intervals Logistic Models Congresses as Topic American Cancer Society

Geographicals4

United States Japan China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Pancreatic Neoplasms Carcinoma, Pancreatic Ductal Deoxycytidine Cell Line, Tumor Adenocarcinoma Mice, Nude Early Detection of Cancer Gene Expression Regulation, Neoplastic Antimetabolites, Antineoplastic Neoplasm Invasiveness CA-19-9 Antigen Xenograft Model Antitumor Assays Neoplasm Metastasis Antineoplastic Agents Cell Proliferation Tumor Markers, Biological Pancreas Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Neoplasm Transplantation Prognosis Apoptosis Prostatic Neoplasms Neoplasm Proteins Ovarian Neoplasms Drug Resistance, Neoplasm Lung Neoplasms Breast Neoplasms Disease Progression Survival Analysis Survival Rate Pancreatitis Colonic Neoplasms Stomach Neoplasms Neoplasms RNA, Messenger RNA, Small Interfering Tumor Cells, Cultured Blotting, Western Genetic Predisposition to Disease Pancreatitis, Chronic Transplantation, Heterologous Carcinoma Pancreatectomy Fluorouracil Combined Modality Therapy Cell Growth Processes Risk Factors Neoplasm Staging Cancer Vaccines Tumor Burden Cell Survival Immunohistochemistry Gene Expression Profiling Cell Movement Signal Transduction Prospective Studies Mutation Retrospective Studies Pancreatic Ducts Risk RNA Interference Down-Regulation Cell Transformation, Neoplastic Smoking Pancreatic Stellate Cells Follow-Up Studies Genes, ras Neoplastic Stem Cells Neovascularization, Pathologic United States Odds Ratio Mice, SCID Risk Assessment DNA, Neoplasm Cell Division Registries Up-Regulation Chemotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Kaplan-Meier Estimate Disease-Free Survival Medical Oncology Antigens, Neoplasm Palliative Care Treatment Outcome Dose-Response Relationship, Drug Cell Cycle Uterine Cervical Neoplasms Drug Screening Assays, Antitumor Colorectal Neoplasms Sensitivity and Specificity Liver Neoplasms Pancreaticoduodenectomy Smad4 Protein Drug Synergism Gene Silencing Epithelial-Mesenchymal Transition Tumor Suppressor Protein p53 MicroRNAs

No FAQ available that match "pancreatic cancer rarely occurs"